Analyst Activity – Piper Jaffray Companies Reiterates Buy on Pfizer (NYSE:PFE)

17

Analyst Ratings For Pfizer (NYSE:PFE)

Today, Piper Jaffray Companies reiterated its Buy rating on Pfizer (NYSE:PFE) with a price target of $54.00.

There are 1 sell rating, 7 hold ratings, 10 buy ratings on the stock.

The current consensus rating on Pfizer (NYSE:PFE) is Buy (Score: 2.50) with a consensus target price of $38.40 per share, a potential 9.53% upside.

Some recent analyst ratings include

  • 11/1/2017-Piper Jaffray Companies Reiterated Rating of Buy.
  • 9/20/2017-Morgan Stanley Upgrade from a “Equal Weight ” rating to a ” Overweight” rating.

Dividend information for Pfizer (NYSE:PFE)

Pfizer (NYSE:PFE) pays an annual dividend of Community Ranking: with a yield of 3.65% and an average dividend growth of 7.70% based on a 3 Year Average.

Dividend History for Pfizer (NYSE:PFE)

  • On 9/27/2017 Pfizer announced a quarterly dividend of $0.32 3.6% with an ex dividend date of 11/9/2017 which will be payable on 12/1/2017.
  • On 6/22/2017 Pfizer announced a quarterly dividend of $0.32 3.75% with an ex dividend date of 8/2/2017 which will be payable on 9/1/2017.
  • On 4/28/2017 Pfizer announced a quarterly dividend of $0.32 3.77% with an ex dividend date of 5/10/2017 which will be payable on 6/1/2017.
  • On 12/12/2016 Pfizer announced a quarterly dividend of $0.32 3.9% with an ex dividend date of 2/1/2017 which will be payable on 3/1/2017.
  • On 9/23/2016 Pfizer announced a quarterly dividend of $0.30 3.5% with an ex dividend date of 11/8/2016 which will be payable on 12/1/2016.
  • On 6/23/2016 Pfizer announced a quarterly dividend of $0.30 3.53% with an ex dividend date of 8/3/2016 which will be payable on 9/1/2016.
  • On 4/28/2016 Pfizer announced a quarterly dividend of $0.30 3.67% with an ex dividend date of 5/11/2016 which will be payable on 6/1/2016.

Recent Insider Trading Activity For Pfizer (NYSE:PFE)
Pfizer (NYSE:PFE) has insider ownership of 0.06% and institutional ownership of 69.01%.

  • On 9/12/2017 Sally Susman, Insider, sold 38,230 with an average share price of $35.00 per share and the total transaction amounting to $1,338,050.00. View SEC Filing
  • On 9/1/2017 Alexander R Mackenzie, Insider, sold 7,350 with an average share price of $34.00 per share and the total transaction amounting to $249,900.00. View SEC Filing
  • On 8/31/2017 Alexander R Mackenzie, Insider, sold 7,350 with an average share price of $34.00 per share and the total transaction amounting to $249,900.00. View SEC Filing
  • On 8/31/2017 Frank A Damelio, EVP, sold 94,409 with an average share price of $34.00 per share and the total transaction amounting to $3,209,906.00. View SEC Filing
  • On 8/31/2017 Ian C Read, CEO, sold 197,168 with an average share price of $34.00 per share and the total transaction amounting to $6,703,712.00. View SEC Filing
  • On 8/21/2017 Laurie J Olson, Insider, sold 8,064 with an average share price of $32.70 per share and the total transaction amounting to $263,692.80. View SEC Filing
  • On 8/7/2017 Alexander R Mackenzie, Insider, sold 15,000 with an average share price of $33.50 per share and the total transaction amounting to $502,500.00. View SEC Filing

Recent Trading Activity for Pfizer (NYSE:PFE)
Shares of Pfizer closed the previous trading session at with shares trading hands.

An ad to help with our costs